These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18929250)

  • 1. Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression.
    Di Filippo C; Marfella R; D'Amico M
    J Am Coll Cardiol; 2008 Oct; 52(16):1350-1; author reply 1351. PubMed ID: 18929250
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease.
    Herrmann J; Soares SM; Lerman LO; Lerman A
    J Am Coll Cardiol; 2008 May; 51(21):2003-10. PubMed ID: 18498952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-proteasome system--micro target for macro intervention?
    Herrmann J; Ciechanover A; Lerman LO; Lerman A
    Int J Cardiovasc Intervent; 2005; 7(1):5-13. PubMed ID: 16019609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
    J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture.
    Marfella R; Di Filippo C; D'Amico M; Paolisso G
    Circ Res; 2007 May; 100(10):e84-5. PubMed ID: 17525372
    [No Abstract]   [Full Text] [Related]  

  • 6. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes.
    Marfella R; D' Amico M; Di Filippo C; Siniscalchi M; Sasso FC; Ferraraccio F; Rossi F; Paolisso G
    Cardiovasc Diabetol; 2007 Oct; 6():35. PubMed ID: 17971205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How APC/C orders destruction.
    Buschhorn BA; Peters JM
    Nat Cell Biol; 2006 Mar; 8(3):209-11. PubMed ID: 16508672
    [No Abstract]   [Full Text] [Related]  

  • 8. Varshavsky's contributions.
    Baumeister W; Bachmair A; Chau V; Cohen R; Coffino P; Demartino G; Deshaies R; Dohmen J; Emr S; Finley D; Hampton R; Hill C; Hochstrasser M; Huber R; Jackson P; Jentsch S; Johnson E; Kwon YT; Pagano M; Pickart C; Rechsteiner M; Scheffner M; Sommer T; Tansey W; Tyers M; Vierstra R; Weissman A; Wilkinson KD; Wolf D
    Science; 2004 Nov; 306(5700):1290-2. PubMed ID: 15550643
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting the ubiquitin-proteasome system in atherosclerosis: status quo, challenges, and perspectives.
    Wilck N; Ludwig A
    Antioxid Redox Signal; 2014 Dec; 21(17):2344-63. PubMed ID: 24506455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the ubiquitin-proteasome system in ER quality control.
    Ye Y
    Essays Biochem; 2005; 41():99-112. PubMed ID: 16250900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-26s proteasome system. New therapeutic implications (review).
    Sujashvili R
    Georgian Med News; 2008; (160-161):48-51. PubMed ID: 18711238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention.
    Breen HB; Espat NJ
    JPEN J Parenter Enteral Nutr; 2004; 28(4):272-7. PubMed ID: 15291411
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteasomes: machines for all reasons.
    Demartino GN; Gillette TG
    Cell; 2007 May; 129(4):659-62. PubMed ID: 17512401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis: anytime, any place, anywhere?
    Pines J; Lindon C
    Nat Cell Biol; 2005 Aug; 7(8):731-5. PubMed ID: 16056263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anaphase-promoting complex/cyclosome: APC/C.
    Acquaviva C; Pines J
    J Cell Sci; 2006 Jun; 119(Pt 12):2401-4. PubMed ID: 16763193
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome-wide approaches to systematically identify substrates of the ubiquitin-proteasome pathway.
    Liu C; Choe V; Rao H
    Trends Biotechnol; 2010 Sep; 28(9):461-7. PubMed ID: 20637515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients.
    Marfella R; Di Filippo C; Laieta MT; Vestini R; Barbieri M; Sangiulo P; Crescenzi B; Ferraraccio F; Rossi F; D'Amico M; Paolisso G
    J Gerontol A Biol Sci Med Sci; 2008 Feb; 63(2):200-3. PubMed ID: 18314458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of ubiquitinated substrates by the PY motif-insertion method for monitoring 26S proteasome activity.
    Saeki Y; Isono E; Toh-E A
    Methods Enzymol; 2005; 399():215-27. PubMed ID: 16338358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin signal: assembly, recognition and termination. Symposium on ubiquitin and signaling.
    Wilkinson KD; Ventii KH; Friedrich KL; Mullally JE
    EMBO Rep; 2005 Sep; 6(9):815-20. PubMed ID: 16113643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of ubiquitinated substrates to protein-unfolding machines.
    Elsasser S; Finley D
    Nat Cell Biol; 2005 Aug; 7(8):742-9. PubMed ID: 16056265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.